In yesterday’s Wall Street session, IO Biotech Inc (NASDAQ:IOBT) shares traded at $1.19, up 53.51% from the previous session.
IOBT stock price is now -8.32% away from the 50-day moving average and -19.21% away from the 200-day moving average. The market capitalization of the company currently stands at $78.40M.
Top 5 Artificial Intelligence Stocks to Buy for 2024
By now, you're well aware of the artificial intelligence boom. You know Big Tech has been investing billions of dollars into it.
According to Next Move Strategy Consulting, the AI market – currently valued at about $100 billion – cold grow twenty-fold by 2030 to more than $2 trillion. That means you may want to strongly consider these top AI stocks. Get our free report, "Top 5 AI Stocks to Buy in 2024."
Click here to automatically get the our FREE Report & Special Offer "5 Best AI Stocks to Invest In"
Sponsored
In other news, Novo Holdings A/S, Stockholder bought 1,000,000 shares of the company’s stock on Sep 11 ’24. The stock was bought for $844,000 at an average price of $0.84. An SEC document containing details of the transaction can be found on the SEC’s website. On Jul 25 ’24, 10% Owner Novo Holdings A/S sold 51,522 shares of the business’s stock. A total of $68,339 was realized by selling the stock at an average price of $1.33. This leaves the insider owning 4,377,927 shares of the company worth $5.21 million. A total of 33.41% of the company’s stock is owned by insiders.
During the past 12 months, IO Biotech Inc has had a low of $0.73 and a high of $2.10. As of last week, the company has a debt-to-equity ratio of 0.02, a current ratio of 7.84, and a quick ratio of 7.84. The fifty day moving average price for IOBT is $1.2984 and a two-hundred day moving average price translates $1.47278 for the stock.
The latest earnings results from IO Biotech Inc (NASDAQ: IOBT) was released for 2024-06-30. The company reported revenue of $21.53 million for the quarter, compared to $21.85 million a year earlier. Comparatively to last year’s same quarter, the company’s quarterly revenue fell -1.46 percent.
